HSD17B13-IN-39

• UNSPSC Description:

  HSD17B13-IN-39 (Compound A) is an inhibitor of hydroxysteroid 17β-dehydrogenase 13 (HSD17B13). HSD17B13-IN-39 can be used for research on liver diseases, metabolic diseases, or cardiovascular diseases, such as NAFLD or NASH[1].

• Target Antigen:

  17β-HSD

• Type:

  Reference compound

• Related Pathways:

  Metabolic Enzyme/Protease

• Applications:

  Metabolism-protein/nucleotide metabolism

• Field of Research:

  Metabolic Disease

• Assay Protocol:

  https://www.medchemexpress.com/hsd17b13-in-39.html

• Solubility:

  10 mM in DMSO

• Smiles:

  OC1=CC=CC(C2=C3C=CC(O)=CC3=CC=N2)=C1

• Molecular Weight:

  237.25

• References & Citations:

  [1]Vincent FLORIO, et al. Substrate selective hsd17b13 inhibitors and uses thereof. WIPO, WO2021211981A1. 2021-10-21.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2730022-55-4